STOCK TITAN

Apnimed: Lawrence G. Miller reports 6.2% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Apnimed, Inc. (APMD) common stock is the subject of Lawrence G. Miller, M.D.’s report of beneficial ownership of 2,708,263 shares, or 6.2% of the class. The reported total includes 2,249,171 shares underlying stock options exercisable within 60 days of September 30, 2026, and shares held of record by five named trusts.

Beneficial ownership 2,708,263 shares As of September 30, 2026
Percentage of class 6.2% Beneficial ownership as of September 30, 2026
Shares underlying stock options 2,249,171 shares Exercisable within 60 days of September 30, 2026
Common shares outstanding 41,630,779 shares As of September 4, 2026
beneficial ownership financial
"beneficial ownership of Common Stock"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shares underlying stock options financial
"shares of Common Stock underlying stock options held"
exercisable within 60 days technical
"stock options held by the Reporting Person that are exercisable within 60 days"
Rule 13d-3(d)(1)(i) regulatory
"in accordance with Rule 13d-3(d)(1)(i)"
sole voting power technical
"Sole Voting Power 2,708,263.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive power technical
"Sole Dispositive Power 2,708,263.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did Lawrence G. Miller report owning in APMD?

Lawrence G. Miller, M.D. reported beneficial ownership of 2,708,263 shares of APMD common stock, or 6.2% of the class. The amount includes 2,249,171 shares underlying options exercisable within 60 days of September 30, 2026, along with shares held by five trusts.

What share count was used to calculate Lawrence G. Miller’s APMD ownership percentage?

The calculation used 41,630,779 shares of Apnimed common stock outstanding as of September 4, 2026, plus 2,249,171 shares underlying options held by Miller that were exercisable within 60 days of September 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





03770Y107

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



Miller Lawrence G.
Signature:/s/ Lawrence G. Miller
Name/Title:Lawrence G. Miller, M.D.
Date:11/16/2026

Keep reading